The inoculation campaign started with 10.2 million doses of the AstraZeneca vaccine from the Serum Institute of India
Bangladesh now has a total of 156,807 doses of Covishield vaccine in stock after administering some 10,043,193 doses since the start of the coronavirus vaccination program in the country.
The Department of Health unveiled the information in a press release on Monday.
Till now, Bangladesh has received 10,200,000 Covishield doses from Serum Institute of India.
According to the press release, out of the 10,043,193 doses used, 5,820,015 people took the first dose and 4,223,178 people took the second dose.
Of those who received the first dose of the vaccine, 3,609,065 were men and 2,210,950 were women.
Meanwhile, 2,698,167males and 1,525,011 females received the second dose.
According to the Department of Health, 7,248,829 people have registered for vaccination in the country till 5:30pm on Monday.
Bangladesh started a pilot vaccination program on January 27 and the nationwide program on February 7 by administering Covishield, the Oxford-AstraZeneca Covid-19 vaccine manufactured by the Serum Institute of India (SII).
However, on April 25, the government suspended administering the first dose of the vaccine, just a day after India stopped exporting the vaccine due to the record-breaking surge in cases and deaths there.
As the SII could not provide the doses of vaccine, a good number of people around Bangladesh are still waiting for their second jabs.
However, on June 1, Bangladesh received the first consignment of 100,620 doses of the Pfizer-BioNTech Covid-19 vaccine, under the Covax scheme run by WHO and Gavi, the Vaccine Alliance.
Meanwhile, China also sent 500,000 doses of the Sinopharm vaccine to Bangladesh as a special gift on May 12. Beijing has said that it will send another 600,000 doses of the vaccine to Dhaka.
Bangladesh started giving the Sinopharm vaccine to medical college students last on June 1.
The Health Services Division will also procure a total of 15 million Sinopharm shots in the next three months — June, July and August.
The country is also negotiating with Russia to buy their Sputnik V vaccine and approved CoronaVac, the Covid-19 vaccine produced by Chinese company Sinovac Biotech.